Great Strides Made In Developing New Medicines For Cancer – Forbes

In contrast to Cancer Drug Targets: The March of the Lemmings – Forbes, which argues that risk averse drug companies rush to the same ‘next great thing’ and breaks down the 1,000 new cancer medicines by category, this more superficial commentary, almost a puff piece for the pharmaceutical industry, just uses the number of 1,000 to be more encouraging.

Expect the reality is somewhere in between.

And of course the biggest fallacy in the Schoen piece is in his line ‘Future medical advancements are our best hope for lessening the burden of cancer to patients, their families and society’ without one word on prevention, where the biggest improvements in outcomes are possible.

Great Strides Made In Developing New Medicines For Cancer – Forbes.